Osang Healthcare Co.,Ltd (KOSDAQ:036220)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,000
+200 (2.04%)
Mar 12, 2026, 3:30 PM KST
Market Cap134.76B -38.1%
Revenue (ttm)119.03B +57.2%
Net Income5.29B
EPS369.60
Shares Out13.75M
PE Ratio26.52
Forward PEn/a
Dividend500.00 (5.10%)
Ex-Dividend DateMar 30, 2026
Volume7,517
Average Volume37,090
Open9,820
Previous Close9,800
Day's Range9,810 - 10,070
52-Week Range8,970 - 23,850
Beta0.29
RSI40.06
Earnings DateMar 25, 2026

About Osang Healthcare Co.,Ltd

Osang Healthcare Co.,Ltd researches, develops, and sells various diagnostic biosensors in South Korea and internationally. The company offers diagnostic biosensors for blood glucose, hemoglobin A1c, cholesterol, immuno diagnosis, molecular diagnosis, and others. It also exports its products to approximately 110 countries worldwide. The company was formerly known as Infopia Co., Ltd. and changed its name to Osang Healthcare Co.,Ltd in April 2017. Osang Healthcare Co.,Ltd was founded in 1996 and is headquartered in Anyang-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 1996
Employees 332
Stock Exchange KOSDAQ
Ticker Symbol 036220
Full Company Profile

Financial Performance

Financial Statements